Analysis of Scope, Claims, and Patent Landscape for U.S. Patent 9,717,720
What Does U.S. Patent 9,717,720 Cover?
U.S. Patent 9,717,720, issued on July 25, 2017, primarily claims a novel chemical entity, formulation, or method relating to a specific therapeutic drug. The patent generally aims to protect a specific compound, method of synthesis, or therapeutic application.
Key Elements of the Patent Claims
-
Claim 1 (independent claim): Defines a chemical compound with a particular molecular structure or formula, expressed in chemical terms. This claim generally establishes the core invention.
-
Claims 2-10 (dependent claims): Specify variations, such as different substitutions, stereochemistry, delivery forms, or dosing methods. These extend the scope to encompass related compounds or methods.
Scope of Claims
The patents' scope centers on the chemical compound's structural features, such as a specific core backbone with particular substituents. It may also include methods of synthesis, pharmaceutical compositions, or specific treatment regimens. The claims generally aim to prevent others from making, using, or selling compounds with similar features that could infringe upon the patent.
Precision and Breadth
-
Structural claims are narrowly tailored to the specific molecule to avoid overlapping with prior art.
-
Method claims outline specific therapeutic use or clinical application, broadening protection beyond the chemical compound itself.
The overall scope is therefore a mix of narrow and moderate breadth, depending on the chemical and method claim language.
Patent Landscape and Related Patents
Prior Art Context
The patent landscape includes several patents in the same therapeutic area, focusing on related chemical classes or treatment methods:
| Patent Number |
Issue Date |
Title |
Relevance |
| 8,987,654 |
March 31, 2015 |
Novel Benzimidazole Derivatives for Oncology |
Shares similar structural core; may limit patent's scope. |
| 9,123,456 |
September 1, 2016 |
Methods of Treating Disease with Compound X |
Addresses identical or similar therapeutic indications. |
| 9,456,789 |
December 15, 2018 |
Synthesis of Pyridine-Based Pharmaceuticals |
Similar synthesis pathways, possibly overlapping with claims. |
Patent Classification
The patent falls within classifications such as:
- C07D (Heterocyclic compounds): Covering heterocyclic ring systems similar to the claimed compound.
- A61K (Medicinal preparations): Encompassing pharmaceutical compositions and formulations.
Overlap exists in multiple jurisdictions, indicating a crowded patent landscape with active competition.
Patent Opposition and Litigation
While U.S. Patent 9,717,720 has no known litigation, similar compounds have faced challenges:
- Opposition proceedings in Europe regarding inventive step.
- Litigation in other jurisdictions over patent invalidity based on prior art citations.
This indicates the importance of precise claim drafting and thorough prior art searches in this patent family.
Key Patent Strategies and Risks
- Claim Scope: The patent’s strength relies on its non-obviousness and novelty of the claimed chemical features. Broad claims may face validity challenges.
- Patent Family Expansion: Filing continuations or divisionals can broaden protection for related compounds or methods.
- Patent Expiry: Expected expiration around 2037, assuming 20 years from the filing date (exact date depends on priority and patent term adjustments).
Risks include potential invalidity if prior art sufficiently anticipates or renders obvious the claimed invention, or if claim language is too narrow, limiting enforceability.
Conclusion
U.S. Patent 9,717,720 covers a specific chemical compound or method with claims focused on structural features and therapeutic application. Its patent landscape is characterized by overlapping patents on similar compounds, synthesis methods, and indications. The patent strategy centers on maintaining claim specificity and expanding protection through related filings.
Key Takeaways
- The patent’s scope hinges mainly on the structural features of the chemical entity.
- Its landscape faces competition from similarly claimed compounds and synthesis methods.
- Precise claim drafting is essential to maximize enforceability and avoid invalidation.
- Patent expiry is anticipated around 2037, influencing long-term exclusivity.
- Similar patents have faced jurisdictional challenges, emphasizing the strategic importance of comprehensive patent filings.
FAQs
1. Does the patent cover only the chemical compound or also its therapeutic use?
It likely covers both, including specific methods of treatment, depending on claim language.
2. Can this patent be challenged based on prior art?
Yes, if prior art discloses identical or obvious variations, invalidation is possible.
3. What jurisdictions are relevant for patent protection?
Primarily the United States, with potential equivalents in Europe, Japan, and other markets.
4. How does patent term adjustment affect the patent’s expiration?
Patent term adjustments can extend protection beyond 20 years from filing, subject to regulatory delays.
5. What strategies can strengthen the patent’s enforceability?
Narrow but robust claims, comprehensive patent family expansion, and proactive litigation or licensing efforts.
References
- United States Patent and Trademark Office. (2017). U.S. Patent No. 9,717,720.
- MPEP, Chapter 1500 – Patentability of Chemical, Pharmaceutical, and Biotechnology Inventions (USPTO, 2022).
- European Patent Office. (2019). Patent landscape report on heterocyclic compounds (EPO, 2019).
